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Abstract
Background: There is uncertain evidence in the dose-response association between overall physical activity levels
and clustering of cardiovascular diseases modifiable risk factors (CVDMRF) in Chinese adults. This study examined
the hypothesis whether inverse dose-response association between overall physical activity levels and clustering of
CVDMRF in Chinese adults exist.
Methods: Twenty-six thousand ninety-three Chinese adult participants were recruited by two independent surveys
in Nanjing and Hefei during 2011 to 2013, from random selected households provided smoking, glucose, lipids,
anthropometric, and blood pressure measurements. Logistic regression model was applied to examine the dose-
response association between overall physical activity (measured by metabolic equivalent task (MET)- minutes per
week) and having ≥1, ≥2, and ≥ 3 CVDMRF (dyslipidemia, hypertension, diabetes, cigarette smoking, and
overweight).
Results: An inverse linear dose-response relationship between physical activity and clustering of CVDMRF was
identified, as increased physical activity levels are associated with lower odds of having clustering of CVDMRF. The
adjusted odds ratio (95% confidence interval) of having ≥1, ≥2, and ≥ 3 CVRF for moderate physical activity group
and high physical activity group was 0.88 (0.79 to 0.98) and 0.88 (0.79 to 0.99), 0.85 (0.78 to 0.92) and 0.85 (0.78 to
0.92), 0.84 (0.76 to 0.91) and 0.81 (0.74 to 0.89), respectively, with low physical activity as reference group.
Conclusions: Among Chinese adults, physical activity level inversely associates with clustering of CVDMRF,
especially in those aged 35–54 years. Health promotion including improve physical activity should be advocated.
The potential role of physical activity in the clustering of CVDMRF warrants further validation.
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Background
Cardiovascular diseases (CVD) as the leading death cause
has affected 290 million Chinese people with CVD and
caused 3.5 million annual death [1]. It is also projected
that annual cardiovascular events will increase by more
than 50% by 2030 in China based on the current the aging
population and the growth of population [2]. Different
from the developed countries in which the prevalence of
some CVD modifiable risk factors has decreased, the
prevalence of CVD modifiable risk factors has increased in
developing countries. In particular, major modifiable risk
factors: current smoking, overweight, diabetes, hyperten-
sion and dyslipdaemia have been found very common in
Chinese adults [3]. For example, it has been estimated that
80.5, 45.9, and 17.2% of Chinese adults had ≥1, ≥2, and ≥ 3
above CVD modifiable risk factors [3].
Emerging evidence suggests physical activity may be rele-
vant to circulating metabolites, including lipoproteins,
lipids, and glucose, which have been associated with risk of
CVD [4, 5]. However, few studies have addressed the asso-
ciation between physical activity and clustering of CVD
modifiable risk factors, particularly in Chinese population.
The goal of this study was to quantify the dose-response as-
sociation between physical activity level and having a clus-
tering of 1 or more, 2 or more, and 3 or more of CVD
modifiable risk factors: dyslipidemia, hypertension, diabetes,
current smoking, and overweight in Chinese adults.
Methods
Data setting
Two independent surveys were implemented in two Chinese
places: Nanjing and Hefei [6]. The Nanjing Community Car-
diovascular Risk Survey was processed by random cluster
sampling [7], between 2011 and 2013, among adults resident
in 6 communities of Nanjing, the capital city of Jiangsu
Province in China. In every Nanjing community, one town-
ship or street district was chosen at random. Six thousand
four hundred forty-five households in the chosen town or
street were incorporated with only one adult aged 20 years
and over sampled from every household, without replace-
ment. Five thousand eight hundred twenty-four participants
completed their clinical examination and survey (response
rate: 90%). The Hefei Community Cardiovascular Risk Sur-
vey was also implemented by a random cluster sampling [6],
between 2012 and 2013 among the adults residents in 10
rural areas of Hefei, the capital city of Anhui Province in
China. In every rural area of Hefei, one township was ran-
domly chosen. Twenty-two thousand thirty-two households
in the chosen rural town were all incorporated with only one
adult aged 20 years and over sampled from every household,
without replacement. Twenty thousand two hundred sixty-
nine participants completed their clinical examination and
survey (response rate: 92%). Ethics approval of this study was
acquired from the Institutional Review Board of Jiangsu
Province Hospital on Integration of Chinese and Western
Medicine (approval number 11–006). Signed, Informed con-
sent was obtained from all study participants.
Clinical measurements
Both in Nanjing and Hefei surveys, research question-
naires were completed by trained research staff through
face-to-face interviews. Question items covered age, gen-
der, race, smoking status, and known diabetes. Partici-
pants who reported having smoked ≥100 cigarettes
during their lifetime were classified as current smokers if
they answered affirmatively to the question, “Do you
smoke cigarettes now?” [3].
Both in Nanjing and Hefei surveys, body measure-
ments and blood pressure measures were taken three
times on the same day by a standardized methodology in
the local clinical center and the mean of the two closest
recordings was recorded as the final measurement. Body
measurements including weight, height and waist cir-
cumference were measured by using a vertical weight
scale and metric scale. Study participants’ weight were
measured to the nearest 10th of a kilogram with wearing
light indoor clothing without shoes. Study participants’
height was measured to the nearest 10th of a centimeter
without wearing shoes. Both in Nanjing and Hefei sur-
veys, above measurements were made by trained ob-
servers who were all asked to attend a training session
to learn the standardized protocol of measurement tech-
niques [8]. Study participants’ body mass index was cal-
culated by their body weight (unit: kg) divided by the
square of their height (unit: meter). Study participants
with BMI ≥25 kg/m2 was defined as overweight [9].
Blood samples were collected for all participants after
an overnight fasting for at least 10 h by trained nurse.
The fasting time was verified prior to collecting the
blood specimen. Participants who had not fasted for at
least 10 h did not have their blood drawn.
Plasma samples for measuring glucose were collected
using vacuum blood collection tubes containing anti-
coagulant sodium fluoride and the serum samples for
measuring lipid profile and creatinine were collected
using vacuum blood collection tubes not containing so-
dium fluoride. Fasting blood specimens collected in
Nanjing were processed at the examination center (Nan-
jing) for urban population and fasting blood specimens
collected in Hefei rural population were shipped by air
to Nanjing examination centre. All specimens were
stored at − 70 °C until laboratory assays were performed.
Plasma glucose, serum creatinine, and serum lipid levels
were measured by automated analyser (Olympus AU600
autoanalyser (Olympus Optical, Tokyo, Japan)). Partici-
pants who currently accepting anti-hypertensive treat-
ment or having a 140mmHg and over of a mean systolic
blood pressure (SBP) and/or a 90 mmHg and over of
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mean diastolic blood pressure (DBP) were defined as
having hypertension [10, 11]. Dyslipidemia was defined
as currently accepting lipid-lowering therapy or having
≥1 of the higher lipid profile measurements as:
total cholesterol ≥5.2 mmol/L, triglycerides ≥1.7 mmol/
L, HDL cholesterol < 1.0 mmol/L, or LDL cholesterol
≥3.4 mmol/L [12]. Participants currently accepting anti-
diabetic therapies (insulin or oral hypoglycemic agents)
or having a high measurement of fasting glucose (fasting
plasma glucose level ≥ 7.0 mmol/L) was defined as hav-
ing diabetes [13].
Physical activity measurements
International Physical Activity Questionnaire was used
to collect physical activity information on household,
transport, and job, as well as those on leisure-time,
sports and recreation. Information about ≥10 min spe-
cific activities by the intensity, daily duration, and total
weekdays during the prior week was acquired from par-
ticipants [14]. Metabolic equivalent task (MET)- minutes
every week (Met Score) were generated from the raw
data. Met Score was also grouped into 3 levels: low
physical activity group (who having < 600 MET-min/
week), moderate physical activity group (who having
600–3000 MET-min/week) and high physical activity
group (who having ≥3000 MET-min/week) [15]. The
MET Score was transformed to its square root due to
the non-normality of distribution.
Statistical analysis
The median and interquartile range was presented for
continuous variables. Transformed Met Score (square
root of Met Score) were compared by t test. Categorical
variables were presented as count and percentages, and
their difference across categories were examined by Chi-
square test. Multivariable Logistic regression model was
applied to assess the association between the trans-
formed Met Score and odds of having ≥1, ≥2, and ≥ 3
major CVD modifiable risk factors by i) quantifying the
odds ratio (OR) by increase of 1 standard deviation (SD)
of transformed Met Score; ii) quantifying the OR by
comparing the physical activity moderate and high level
with the low level. Dose-response relationship between
the transformed Met Score and odds of having ≥1, ≥2,
and ≥ 3 major CVD modifiable risk factors was also ex-
amined by natural cubic spline model.
All statistical analyses were processed using STATA
MP 15.0. All P-values were estimated by two-tailed tests
and a P-value < 0.05 was taken as significance level.
Results
The characteristics of study participants in Nanjing sur-
vey sample, Hefei survey sample and the pooled survey
Table 1 Characteristics of study participants
Characteristics Survey-1 (Nanjing) Survey-2 (Hefei) Pooled data
Participants, n 5824 20,269 26,093
Age, years 52.0 (43.0 to 59.0) 51.0 (43.0 to 58.0) 51.0 (43.0 to 58.0)
Women, n (%) 3278 (56.3) 11,905 (58.7) 15,183 (58.2)
Current smoking, n (%) 1571 (28.0) 4687 (23.3) 6258 (24.0)
Hypertension, n (%) 2259 (38.8) 9228 (45.5) 11,487 (44.0)
Type 2 diabetes, n (%) 472 (8.1) 1832 (9.0) 2304 (8.8)
Body mass index, kg/m2 23.6 (21.4 to 26.1) 24.1 (21.8 to 26.5) 24.0 (22.1 to 26.8)
Waist circumference, cm 80.0 (73.3 to 87.0) 81.6 (74.3 to 88.7) 81.3 (74.0 to 88.4)
Systolic blood pressure, mmHg 128 (116 to 143) 132 (120 to 148) 131 (119 to 147)
Diastolic blood pressure, mmHg 80.5 (73.5 to 88.5) 82.5 (75.0 to 90.5) 82.0 (75.0 to 90.0)
Fasting glucose, mmol/L 5.4 (4.9 to 5.9) 5.3 (4.8 to 5.2) 5.3 (4.8 to 5.8)
Triglyceride, mmol/L 1.2 (0.8 to 1.7) 1.3 (0.9 to 1.8) 1.2 (0.9 to 1.8)
Total cholesterol, mmol/L 4.4 (3.9 to 4.9) 4.6 (4.0 to 5.2) 4.5 (4.0 to 5.1)
High density lipoprotein cholesterol, mmol/L 1.3 (1.1 to 1.5) 1.3 (1.1 to 1.5) 1.3 (1.1 to 1.5)
Low density lipoprotein cholesterol, mmol/L 2.4 (2.0 to 2.9) 2.6 (2.2 to 3.1) 2.5 (2.1 to 3.0)
Dyslipidaemia, n (%) 2583 (44.4) 10,463 (51.6) 13,046 (50.0)
Overweight, n (%) 2341 (40.2) 9187 (45.3) 11,528 (44.2)
Having ≥1 CVD modifiable risk factor, n (%) 4692 (80.6) 17,118 (84.5) 21,810 (83.6)
Having ≥2 CVD modifiable risk factors, n (%) 2914 (50.0) 11,421 (56.4) 14,335 (54.9)
Having ≥3 CVD modifiable risk factors, n (%) 1275 (21.9) 5422 (26.8) 6697 (25.7)
Continuous variables were presented as median (interquartile range); categorical variables were presented as number (percentage)
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samples are presented in Table 1. The prevalence of
current smoking, overweight, dyslipidemia, hypertension,
and diabetes was 24.0, 44.2, 50.0, 44.0 and 8.0% in the
pooled survey sample, respectively. The prevalence of
each CVRF above was 28.0, 40.2, 44.4, 38.8, and 8.1% in
Nanjing survey sample and 23.3, 45.3, 51.6, 45.5 and
9.0% in Hefei sample, respectively. The prevalence of
having ≥1, ≥2 and ≥ 3 CVD modifiable risk factors was
83.6, 54.9 and 25.7% in the pooled survey sample, re-
spectively. The prevalence of having ≥1, ≥2 and ≥ 3 CVD
modifiable risk factors was higher in Hefei survey sample
comparing with Nanjing sample, as 84.5, 56.4, and 26.8%
in Hefei survey sample and 80.6, 50.0 and 21.9% in Nan-
jing survey sample, respectively.
The distribution of physical activity levels (trans-
formed Met Score) was presented in Table 2 by the sta-
tus of clustering of CVD modifiable risk factors.
Participants with clustering of CVD modifiable risk fac-
tors was more likely to have lower physical activity com-
paring with those without clustering of CVD modifiable
risk factors, as the median (IQR) of transformed Met
Score was 48.9 (33.8 to 70.2), 47.8 (33.6 to 70.7) and
46.2 (32.9 to 69.1) among those with ≥1, ≥2 and ≥ 3
CVRF; 50.0 (34.1 to 71.9), 50.2 (34.1 to 72.0), and 50.1
(34.2 to 72.0) among those without ≥1, ≥2 and ≥ 3 CVD
modifiable risk factors, respectively. Similarly, signifi-
cantly lower physical activity was found among partici-
pants with clustering of CVD modifiable risk factors
comparing with those without clustering of CVD modifi-
able risk factors in each survey sample and by sex. In the
age-stratified analysis, the significant difference was
found in age group 35–44 years and 45–54 years.
The dose-response association between transformed
Met Score and adjusted odds ratio (OR) of having ≥1, ≥2
and ≥ 3 CVD modifiable risk factors was presented in
Fig. 1. Linear dose-response relationships were found in
overall, by survey, sex, and age groups (non-linear test:
all P-value> 0.05).
As presented in Table 3, the adjusted OR of having ≥1,
≥2 and ≥ 3 CVD modifiable risk factors by per SD in-
crease was 0.98 (0.94 to 1.01), 0.96 (0.93 to 0.99) and
0.93 (0.90 to 0.96), respectively. In the site-specific ana-
lysis, the significant adjusted OR of having ≥1, ≥2, and ≥
3 CVD modifiable risk factors was found in Nanjing sur-
vey, Hefei survey and both surveys. In the sex-specific
analysis, adjusted OR of having ≥1 CVD modifiable risk
Table 2 Distribution of physical activity levels by cardiovascular disease risk factors clustering status among Chinese adults
Having ≥1 CVD modifiable
risk factor
P Having ≥2 CVD modifiable
risk factors
P Having ≥3 CVD modifiable
risk factors
P
Met Score, median (Inter-
quartile range)
Yes No Yes No Yes No
Overall 48.9 (33.8 to
70.2)
50.0 (34.1 to
71.9)
0.017 47.8 (33.6 to
70.7)
50.2 (34.1 to
72.0)
0.003 46.2 (32.9 to
69.1)
50.1 (34.2 to
72.0)
<
0.001
Survey site
Nanjing 44.2 (29.2 to
68.0)
47.1 (31.0 to
69.3)
0.028 43.5 (28.5 to
67.1)
45.7 (30.5 to
69.2)
0.013 43.0 (27.6 to
64.6)
45.4 (30.2 to
69.3)
0.003
Hefei 49.6 (35.3 to
71.9)
51.3 (35.5 to
72.2)
0.043 50.2 (35.4 to
71.3)
51.2 (35.5 to
72.7)
0.002 50.0 (34.5 to
69.8)
51.4 (35.5 to
72.7)
<
0.001
Sex
Male 48.3 (32.5 to
72.7)
51.4 (33.5 to
76.1)
0.010 47.0 (32.3 to
71.9)
50.0 (33.2 to
74.9)
0.002 46.1 (31.5 to
70.2)
50.0 (33.3 to
74.4)
0.002
Female 49.6 (34.2 to
68.2)
50.0 (43.6 to
71.0)
0.183 48.3 (34.9 to
69.2)
51.4 (34.6 to
71.0)
0.012 48.1 (34.6 to
68.2)
50.6 (34.7 to
71.0)
0.003
Age group
< 35 years 46.6 (30.5 to
62.0)
47.3 (33.4 to
68.9)
0.098 44.4 (25.8 to
62.2)
47.3 (35.5 to
86.0)
0.072 48.3 (17.8 to
63.4)
47.3 (32.9 to
93.1)
0.098
35–44 years 48.8 (32.4 to
73.2)
49.3 (33.5 to
75.3)
0.047 47.9 (31.3 to
73.2)
49.3 (33.5 to
75.1)
0.016 46.7 (30.0 to
73.6)
49.6 (33.2 to
74.8)
0.037
45–54 years 48.5 (34.5 to
72.7)
51.0 (35.5 to
73.5)
0.036 47.3 (34.8 to
72.9)
50.8 (34.5 to
73.4)
0.026 49.4 (33.4 to
71.6)
51.4 (35.1 to
73.9)
0.021
55–64 years 49.1 (33.3 to
67.9)
50.0 (34.4 to
68.7)
0.056 50.0 (32.4 to
67.3)
50.3 (34.3 to
69.1)
0.072 49.1 (32.2 to
67.5)
50.2 (34.6 to
69.4)
0.063
65–74 years 49.5 (34.0 to
65.1)
50.0 (32.9 to
67.7)
0.062 48.9 (33.9 to
65.1)
49.8 (34.0 to
65.8)
0.083 49.1 (33.7 to
65.4)
50.4 (35.3 to
64.9)
0.078
≥ 75 years 49.7 (29.4 to
68.1)
50.1 (43.7 to
89.6)
0.056 48.9 (27.9 to
68.1)
49.8 (36.3 to
78.4)
0.076 46.2 (24.5 to
53.9)
49.2 (39.5 to
79.2)
0.061
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Fig. 1 Adjusted dose-response relationship between Met Scores and odds of having ≥1, 2, 3 cardiovascular disease risk factors among Chinese
adults. In the pooled dataset, sex, age group and survey site were adjusted; in the survey site specific dataset, sex and age group were adjusted
Table 3 Adjusted association between physical activity scores (per SD increase) and odds of having ≥1, 2, 3 CVD modifiable risk
factor among Chinese adults
Adjusted Odds ratio (95 confidence interval)
Having ≥1 CVD modifiable risk factor Having ≥2 CVD modifiable risk factors Having ≥3 CVD modifiable risk factors
Overall a 0.98 (0.94 to 1.01) 0.96 (0.93 to 0.99) 0.93 (0.90 to 0.96)
Survey site b
Nanjing 0.92 (0.86 to 0.99) 0.95 (0.90 to 1.01) 0.90 (0.83 to 0.96)
Hefei 0.98 (0.94 to 1.03) 0.96 (0.93 to 0.99) 0.93 (0.89 to 0.97)
Sex c
Male 0.94 (0.87 to 1.01) 0.93 (0.89 to 0.97) 0.90 (0.86 to 0.94)
Female 0.98 (0.93 to 1.03) 0.96 (0.93 to 0.99) 0.94 (0.90 to 0.99)
Age group d
< 35 years 0.99 (0.97 to 1.02) 0.92 (0.88 to 0.96) 0.72 (0.33 to 1.57)
35–44 years 0.97 (0.95 to 0.99) 0.97 (0.95 to 0.99) 0.93 (0.87 to 0.99)
45–54 years 1.00 (0.97 to 1.03) 0.96 (0.94 to 0.98) 0.92 (0.87 to 0.98)
55–64 years 0.95 (0.90 to 1.00) 0.98 (0.96 to 1.00) 0.97 (0.91 to 1.03)
65–74 years 0.95 (0.89 to 1.01) 0.99 (0.98 to 1.00) 0.95 (0.85 to 1.06)
≥ 75 years 0.68 (0.33 to 1.03) 0.89 (0.75 to 1.03) 0.54 (0.07 to 1.02)
a indicates sex, survey site, and age group were adjusted; b indicates sex and age group were adjusted; c indicates survey site and age group were adjusted; d
indicates sex and survey site were adjusted
The odds ratio was estimated by per SD (28 transformed Met Score) increase
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factors was insignificant in both gender; the adjusted OR
of having ≥2, and ≥ 3 CVD modifiable risk factors were
both significant in both genders. In the age-stratified
analysis, the significant adjusted OR of having ≥1 CVD
modifiable risk factors was found in those aged 35–44
years; the adjusted OR of having ≥2, and ≥ 3 CVD modi-
fiable risk factors was significant in those aged 35–44
years and those aged 45–54 years, respectively.
In Table 4, the adjusted OR of having ≥1, ≥2, and ≥ 3
CVD modifiable risk factors for moderate physical activ-
ity group and high physical activity group was 0.88 (0.79
to 0.98) and 0.88 (0.79 to 0.99), 0.85 (0.78 to 0.92) and
0.85 (0.78 to 0.92), 0.84 (0.76 to 0.91) and 0.81 (0.74 to
0.89), respectively, with low physical activity as reference
group. In the stratified analysis, the significant adjusted
OR of having ≥2 and ≥ 3 CVD modifiable risk factors
was found for moderate physical activity group and high
physical activity group in each survey sample, and 35–44
and 45–54 age groups, respectively.
Discussion
Based on two independent surveys from two provinces
in China, this study comprehensively examined the dose
response associations of self-reported total physical ac-
tivity and clustering of CVD modifiable risk factors
among Chinese adults. Higher prevalence of clustering
across CVD modifiable risk factors is associated with
lower physical activity. The increase of the physical ac-
tivity from < 600 MET-min/week to 600–3000 MET-
min/week is associated with 12, 15 and 16% decreased
odds of having ≥1, ≥2 and ≥ 3 CVD modifiable risk fac-
tors. Although prevalence of each CVD modifiable risk
factors was different over two surveys, the consistently
similar findings are revealed in each survey. Improving
physical activity among younger persons before the im-
pacts of chronic disease become largely irreversible,
could help to improve life expectancy.
Physical activity and single CVD modifiable risk fac-
tors in Chinese population have been addressed in prior
studies. For example, Lao et al. identified inverse dose-
response association between leisure-time physical activ-
ity and diabetes risk as higher levels of leisure-time
physical activity are associated with a lower risk of dia-
betes in Chinese people with impaired fasting glucose
[16]. Yang et al. found that household physical activity
was inversely associated with the risk of type 2 diabetes
in among urban males in northern China [17]. Pang
et al. reveals that higher physical activity is associated
with lower concentration of atherogenic lipoprotein and
cholesterol and lower levels of inflammation in Chinese
Table 4 Adjusted association between physical activity scores category and odds of having ≥1, 2, 3 CVD modifiable risk factors
among Chinese adults
Adjusted Odds Ratio (95% confidence interval)
Having ≥1 CVD modifiable risk factor Having ≥2 CVD modifiable risk factors Having ≥3 CVD modifiable risk factors
Moderate physical
activity
High physical
activity
Moderate physical
activity
High physical
activity
Moderate physical
activity
High physical
activity
Overall a 0.88 (0.79 to 0.98) 0.88 (0.79 to 0.99) 0.85 (0.78 to 0.92) 0.85 (0.78 to 0.92) 0.84 (0.76 to 0.91) 0.81 (0.74 to 0.89)
Survey site b
Nanjing 0.83 (0.68 to 1.01) 0.79 (0.64 to 0.97) 0.75 (0.65 to 0.88) 0.71 (0.61 to 0.83) 0.71 (0.60 to 0.84) 0.65 (0.55 to 0.78)
Hefei 0.88 (0.77 to 1.01) 0.89 (0.78 to 1.01) 0.87 (0.79 to 0.96) 0.88 (0.80 to 0.96) 0.87 (0.78 to 0.96) 0.84 (0.76 to 0.93)
Sex c
Male 0.86 (0.78 to 0.96) 0.88 (0.73 to 1.03) 0.83 (0.63 to 1.02) 0.81 (0.72 to 0.91) 0.82 (0.60 to 1.04) 0.80 (0.73 to 0.87)
Female 0.99 (0.87 to 1.13) 0.97 (0.85 to 1.11) 0.97 (0.87 to 1.09) 0.98 (0.87 to 1.09) 0.93 (0.81 to 1.06) 0.95 (0.83 to 1.09)
Age group d
< 35 years 0.97 (0.30 to 3.09) 0.67 (0.19 to 2.30) 0.27 (0.08 to 0.84) 0.51 (0.16 to 1.61) 0.26 (0.06 to 1.12) 0.33 (0.08 to 1.41)
35–44
years
0.77 (0.65 to 0.90) 0.81 (0.69 to 0.95) 0.69 (0.60 to 0.79) 0.70 (0.61 to 0.80) 0.71 (0.59 to 0.85) 0.69 (0.57 to 0.82)
45–54
years
0.76 (0.62 to 0.95) 0.77 (0.62 to 0.95) 0.77 (0.67 to 0.89) 0.82 (0.71 to 0.95) 0.76 (0.65 to 0.88) 0.69 (0.59 to 0.81)
55–64
years
0.92 (0.70 to 1.20) 0.96 (0.74 to 1.26) 0.98 (0.83 to 1.16) 0.96 (0.81 to 1.13) 0.87 (0.74 to 1.03) 0.90 (0.76 to 1.06)
65–74
years
0.65 (0.41 to 1.03) 0.84 (0.54 to 1.32) 0.98 (0.76 to 1.28) 0.97 (0.75 to 1.27) 1.00 (0.78 to 1.29) 0.91 (0.70 to 1.17)
≥ 75 years 0.54 (0.09 to 3.62) 0.48 (0.09 to 2.54) 0.71 (0.21 to 2.38) 0.83 (0.25 to 2.76) 0.75 (0.22 to 2.56) 0.23 (0.06 to 0.95)
a indicates sex, survey site, and age group were adjusted; b indicates sex and age group were adjusted; c indicates survey site and age group were adjusted; d
indicates sex and survey site were adjusted
Adjusted odds ratio was estimated with low physical activity as reference group
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population [18]. Li et al. found higher level physical ac-
tivity is related to between glycemic control and insulin
sensitivity in southern Chinese population [19]. Similar
with these findings, we identified inverse linear dose-
response relationship between higher total physical ac-
tivity level and lower prevalence of having ≥1, ≥2 and ≥ 3
CVD modifiable risk factors among Chinese adults. In-
stead of measuring parts of daily physical activity (i.e.
leisure-time physical activity, sedentary time, or house-
hold physical activity), the overall activity measurement
incorporating all parts of daily physical activity were
undertaken in this study. And instead of investigating
the single CVD modifiable risk factors, this study fo-
cused on the clustering status of CVD modifiable risk
factors, which would generally reflect the individual
CVD health and potential future CVD risk. In this study,
about 15% decreased prevalence of having ≥2 CVD risk
factors might be avoided if the inactive individuals ((<
600 MET-min/week) improved their physical activity to
moderate level (600–3000 MET-min/week).
In this study, we investigated the dose-response associ-
ation between physical activity and clustering of CVD
modifiable risk factors not only in the general population
but also in the different age-stratified subpopulation.
The significant inverse association (higher prevalence of
clustering across CVD modifiable risk factors is associ-
ated with lower physical activity) was identified in people
aged 35–44 years. Among people aged less than 35 years,
the insignificant association might suggest that physical
activity might not take a significant role in the early on-
set of clustering of CVD modifiable risk factors [20],
which of course need further validation in the external
young populations. Among people aged more than 55
years, the existing comorbidities might take a significant
role of the clustering of CVD modifiable risk factors
[21], which would attenuate the contribution of physical
activity. Based on this study, the health promotion pro-
grams including improving general physical activities
should be advocated in the Chinese population aged 35–
54 by health policy makers.
Potential biological mechanism underlying the cardio-
vascular protective effects of physical activity against the
clustering of CVD modifiable risk factors include some fa-
vorable modification effects in adiposity, insulin sensitiv-
ity, lipid profiles and systemic inflammation [16, 22–24].
Experimental studies also revealed that physical activity
helps to improve body muscle mass and stimulates the up-
take of glucose in muscles [25, 26] and reduce triglycer-
ides and ceramides and improve insulin sensitivity [27].
As the strength of this study, overall > 90% response rate
was achieved by this study, which made the study sample
well represent local populations. The high response rate
was achieved by household investigation and face-to-face
interview by trained research staff. The limitation of this
study is the utilization of cross-sectional survey datasets,
whereby physical activity measurements and CVD modifi-
able risk factors were evaluated at same time. Therefore, it
is impossible to process causal inference between physical
activity and clustering of CVD modifiable risk factors. Fu-
ture studies within in prospective cohort data would be
the next step in testing above associations. Some other
confounders like comorbidities (like existing CVD) could
also alter the association between physical activity and
clustering of CVD modifiable risk factors. However, more
comorbidities more not available in this study. Finally, fu-
ture external replication studies with adjustment of poten-
tial comorbidities, alongside meta-analysis are warranted
to better understanding whether physical activity does
have the potential modification role in the clustering of
CVD modifiable risk factors. Some other blood markers
that could confound the findings of this study, like C-
reactive protein were not accessible in this study and its
confounding effect could not be addressed in this study.
Instead of using International Physical Activity Question-
naire to assess physical activity, accelerometers or other
wearables might be preferred in recent studies. Future
replication studies using wearables to assess physical activ-
ity are warranted.
Conclusion
In conclusion, in Chinese adults, physical activity level
inversely associates with clustering of CVD modifiable
risk factors, especially in Chinese adults aged 35 to 54
years. Health promotion programme including improve
physical activity level should be advocated. Physical ac-
tivity has the potential modification role in the clustering
of CVD modifiable risk factors that warrants further val-
idation in the future prospective cohort studies.
Abbreviations
CVD: Cardiovascular diseases; CVDMRF: Clustering of cardiovascular diseases
modifiable risk factors; MET: Metabolic equivalent task; BMI: Body mass index;
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; OR: Odds ratio;
CI: Confidence interval
Acknowledgements
We are also grateful to all the individuals who conducted the data collection
and entry.
Authors’ contributions
RS, YY, YC, and DY designed the study. RQ, YC, and DY collected the data.
RS, YC and DY conducted the data analyses. RS, YC, RQ, YY and DY drafted
the manuscript. RS, YY, YC, RQ and DY edited the manuscript. All authors
have read and approved the final manuscript.
Funding
This work received supports from the National Natural Science Foundation of
China (grant number 81800299). The funder had no role in the design of the
study and collection, analysis, and interpretation of data and in writing the
manuscript.
Availability of data and materials
The data used and/or analyzed during the study are available from the
corresponding author on reasonable request.
Shi et al. BMC Cardiovascular Disorders          (2020) 20:347 Page 7 of 8
Ethics approval and consent to participate
Ethics approval of this study was acquired from the Institutional Review
Board of Jiangsu Province Hospital on Integration of Chinese and Western
Medicine (approval number 11–006). Signed, Informed consent was obtained
from all study participants.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi’an
Jiaotong University, Xi’an 713300, China. 2Jiangsu Province Hospital on
Integration of Chinese and Western Medicine, Nanjing 210028, China.
3Department of Cardiovascular surgery, The First Affiliated Hospital of Xi’an
Jiaotong University, Xi’an 713300, China. 4Primary Care Centre Versus Arthritis,
School of Primary, Community and Social Care, Keele University, Keele ST5
5BG, UK.
Received: 19 March 2020 Accepted: 17 July 2020
References
1. Zhu J, Yu X, Zheng Y, Li J, Wang Y, Lin Y, He Z, Zhao W, Chen C, Qiu K, Wu
J. Association of glucose-lowering medications with cardiovascular
outcomes: an umbrella review and evidence map. Lancet Diabetes
Endocrinol. 2020.
2. Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J,
Bibbins-Domingo K, Shen YM, He J, Goldman L. Future cardiovascular
disease in China: markov model and risk factor scenario projections from
the coronary heart disease policy model-China. Circ Cardiovasc Qual
Outcomes. 2010;3(3):243–52.
3. Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, Reynolds RF, Whelton PK,
He J. Prevalence of cardiovascular disease risk factor clustering among the
adult population of China: results from the international collaborative study
of cardiovascular disease in Asia (InterAsia). Circulation. 2005;112(5):658–65.
4. Qin L, Corpeleijn E, Jiang C, Thomas GN, Schooling CM, Zhang W, Cheng
KK, Leung GM, Stolk RP, Lam TH. Physical activity, adiposity, and diabetes
risk in middle-aged and older Chinese population: the Guangzhou biobank
cohort study. Diabetes Care. 2010;33(11):2342–8.
5. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Lancet
physical activity series working group. Effect of physical inactivity on major
non-communicable diseases worldwide: an analysis of burden of disease
and life expectancy. Lancet. 2012;380(9838):219–29.
6. Yu L, Cai Y, Qin R, Zhao B, Li X. Association between triglyceride glucose
index and abnormal liver function in both urban and rural Chinese adult
populations: findings from two independent surveys. Medicine (Baltimore).
2019;98(50):e18265.
7. Yu D, Chen T, Qin R, Cai Y, Jiang Z, Zhao Z, Simmons D. Association
between lung capacity and abnormal glucose metabolism: findings from
China and Australia. Clin Endocrinol. 2016;85(1):37–45.
8. Yu D, Chen T, Cai Y, Zhao Z, Simmons D. Association between pulmonary
function and renal function: findings from China and Australia. BMC
Nephrol. 2017;18(1):143–017-0565-y.
9. Yu D, Yang W, Chen T, Cai Y, Zhao Z, Simmons D. Hypertriglyceridemic-
waist is more predictive of abnormal liver and renal function in an
Australian population than a Chinese population. Obes Res Clin Pract. 2018;
12(5):438–44.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones
DW, Materson BJ, Oparil S, Wright JT Jr, et al. The seventh report of the joint
National Committee on prevention, detection, evaluation, and treatment of
high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.
11. 1999 World Health Organization--International Society of Hypertension
Guidelines for the Management of Hypertension. Guidelines sub-committee.
Blood Press Suppl. 1999;1:9–43.
12. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J,
InterASIA collaborative group. Prevalence of the metabolic syndrome and
overweight among adults in China. Lancet. 2005;365(9468):1398–405.
13. Yu D, Huang J, Hu D, Chen J, Cao J, Li J. Is an appropriate cutoff of
hypertriglyceridemic waist designated for type 2 diabetes among Chinese
adults? Clin Nutr. 2010;29(2):192–8.
14. Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, Casanova A,
Swaminathan S, Anjana RM, Kumar R, Rosengren A, Wei L, Yang W,
Chuangshi W, Huaxing L, Nair S, Diaz R, Swidon H, Gupta R,
Mohammadifard N, Lopez-Jaramillo P, Oguz A, Zatonska K, Seron P, Avezum
A, Poirier P, Teo K, Yusuf S. The effect of physical activity on mortality and
cardiovascular disease in 130 000 people from 17 high-income, middle-
income, and low-income countries: the PURE study. Lancet. 2017;
390(10113):2643–54.
15. Oyeyemi AL, Moss SJ, Monyeki MA, Kruger HS. Measurement of physical
activity in urban and rural south African adults: a comparison of two self-
report methods. BMC Public Health. 2016;16(1):1004 -016-3693-6.
16. Lao XQ, Deng HB, Liu X, Chan TC, Zhang Z, Chang LY, Yeoh EK, Tam T, Wong
MCS, Thomas GN. Increased leisure-time physical activity associated with lower
onset of diabetes in 44 828 adults with impaired fasting glucose: a population-
based prospective cohort study. Br J Sports Med. 2019;53(14):895–900.
17. Yang J, Zhang YL, Ye J, Guo Q, Sun YN, Zeng Q. Association between
household physical activity level and type 2 diabetes among urban males in
northern China. Public Health. 2018;163:113–20.
18. Pang Y, Kartsonaki C, Du H, Millwood IY, Guo Y, Chen Y, Bian Z, Yang L,
Walters R, Bragg F, Lv J, Yu C, Chen J, Peto R, Clarke R, Collins R, Bennett
DA, Li L, Holmes MV, Chen Z. Physical activity, sedentary leisure time,
circulating metabolic markers, and risk of major vascular diseases. Circ
Genom Precis Med. 2019;12(9):386–96.
19. Li L, Yin X, Yu D, Li H. Impact of physical activity on glycemic control and
insulin resistance: a study of community-dwelling diabetic patients in
eastern China. Intern Med. 2016;55(9):1055–60.
20. Rees R, Kavanagh J, Harden A, Shepherd J, Brunton G, Oliver S, Oakley A.
Young people and physical activity: a systematic review matching their
views to effective interventions. Health Educ Res. 2006;21(6):806–25.
21. McPhee JS, French DP, Jackson D, Nazroo J, Pendleton N, Degens H.
Physical activity in older age: perspectives for healthy ageing and frailty.
Biogerontology. 2016;17(3):567–80.
22. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C. ATTI
CA study: the associations between leisure-time physical activity and
inflammatory and coagulation markers related to cardiovascular disease: the
ATTICA study. Prev Med. 2005;40(4):432–7.
23. Vuori IM. Health benefits of physical activity with special reference to
interaction with diet. Public Health Nutr. 2001;4(2B):517–28.
24. Bassuk SS, Manson JE. Epidemiological evidence for the role of physical
activity in reducing risk of type 2 diabetes and cardiovascular disease. J
Appl Physiol (1985). 2005;99(3):1193–204.
25. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose
uptake. Physiol Rev. 2013;93(3):993–1017.
26. Cartee GD. Roles of TBC1D1 and TBC1D4 in insulin- and exercise-stimulated
glucose transport of skeletal muscle. Diabetologia. 2015;58(1):19–30.
27. Bird SR, Hawley JA. Update on the effects of physical activity on insulin
sensitivity in humans. BMJ Open Sport Exerc Med. 2017;2(1):e000143.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Shi et al. BMC Cardiovascular Disorders          (2020) 20:347 Page 8 of 8
